AKYA / Title: Akoya Biosciences, Inc. (AKYA) CEO Brian McKelligon on Q2 2022 Results - Earnings Call Transcript

Akoya Biosciences, Inc. (NASDAQ:AKYA ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Participants Priyam Shah - IR Brian McKellig more_horizontal

Akoya Biosciences (AKYA) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to lo more_horizontal

MARLBOROUGH, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today annou more_horizontal

Akoya Biosciences makes single-cell imaging solutions to aid in phenotyping cells. The company is not profitable. more_horizontal

Shares of Akoya Biosciences AKYA, -2.46% on Wednesday dropped 10% to $5.00 in after-hours trading after the company said it fired its chief medical of more_horizontal

Akoya Biosciences, Inc. (NASDAQ:AKYA ) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Priyam Shah - Investor Relations B more_horizontal

Akoya Biosciences (AKYA) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to lo more_horizontal

Akoya Biosciences, Inc. (NASDAQ:AKYA ) Q4 2022 Earnings Conference Call March 6, 2023 5:00 PM ET Company Participants Priyam Shah - Head, Investor Rel more_horizontal